Tag: $Tourmaline Bio

Novartis to acquire Tourmaline Bio for $1.4 billion

Novartis (NOVN.S), will acquire Tourmaline Bio (TRML.O), for $48 per share, valuing the New York-based biopharmaceutical company at $1.4 billion on a fully diluted basis, the Swiss pharma giant said on Tuesday.